1. Low SKP2 expression is predictive of sensitivity to an MDM2 antagonist in p53 wild-type AML. (October 2022) Authors: Kucia-Tran, J.; Bevan, L.; Chessari, G.; Fazal, L.; Ferrari, N.; Lyons, J.; Saini, H.; Wallis, N.; Ward, G.; Ahn, M. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗